Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy MEDIFAST stock
Learn how to easily invest in MEDIFAST stock.
MEDIFAST INC is a personal services business based in the US. MEDIFAST shares (MED) are listed on the NYSE and all prices are listed in US Dollars. MEDIFAST employs 984 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in MEDIFAST
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – MED – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
MEDIFAST stock price (NYSE: MED)Use our graph to track the performance of MED stocks over time.
MEDIFAST shares at a glance
|Latest market close||$182.94|
|52-week range||$154.67 - $288.71|
|50-day moving average||$178.32|
|200-day moving average||$193.72|
|Wall St. target price||$327.33|
|Dividend yield||$5.9 (3.66%)|
|Earnings per share (TTM)||$14.02|
Buy MEDIFAST shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy MEDIFAST stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
MEDIFAST price performance over time
|1 week (2022-06-23)||-0.34%|
|1 month (2022-05-28)||N/A|
|3 months (2022-03-29)||3.57%|
|6 months (2021-12-31)||-12.65%|
|1 year (2021-07-01)||-36.11%|
|2 years (2020-07-01)||29.50%|
|3 years (2019-07-01)||48.74%|
|5 years (2017-06-30)||341.14%|
Is MEDIFAST stock undervalued or overvalued?
Valuing MEDIFAST stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of MEDIFAST's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
MEDIFAST's P/E ratio
MEDIFAST's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 14x. In other words, MEDIFAST shares trade at around 14x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
MEDIFAST's PEG ratio
MEDIFAST's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.95. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into MEDIFAST's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
MEDIFAST's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $226.7 million.
The EBITDA is a measure of a MEDIFAST's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.6 billion|
|Operating margin TTM||13.63%|
|Gross profit TTM||$1.1 billion|
|Return on assets TTM||36.53%|
|Return on equity TTM||84.29%|
|Market capitalisation||$2.2 billion|
TTM: trailing 12 months
MEDIFAST share dividends
Dividend payout ratio: 43.65% of net profits
Recently MEDIFAST has paid out, on average, around 43.65% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.66% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), MEDIFAST shareholders could enjoy a 3.66% return on their shares, in the form of dividend payments. In MEDIFAST's case, that would currently equate to about $5.9 per share.
While MEDIFAST's payout ratio might seem fairly standard, it's worth remembering that MEDIFAST may be investing much of the rest of its net profits in future growth.
MEDIFAST's most recent dividend payout was on 7 August 2022. The latest dividend was paid out to all shareholders who bought their shares by 26 June 2022 (the "ex-dividend date").
MEDIFAST share price volatility
Over the last 12 months, MEDIFAST's shares have ranged in value from as little as $154.67 up to $288.7061. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while MEDIFAST's is 1.3203. This would suggest that MEDIFAST's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Medifast, Inc. , through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is headquartered in Baltimore, Maryland. .
MEDIFAST in the news
Why Medifast (MED) is a Top Momentum Stock for the Long-Term
Is Medifast (MED) a Solid Growth Stock? 3 Reasons to Think "Yes"
Middle Market Leaders 2022: Medifast Inc.
Frequently asked questionsWhat percentage of MEDIFAST is owned by insiders or institutions?
Currently 4.429% of MEDIFAST shares are held by insiders and 88.935% by institutions. How many people work for MEDIFAST?
Latest data suggests 984 work at MEDIFAST. When does the fiscal year end for MEDIFAST?
MEDIFAST's fiscal year ends in December. Where is MEDIFAST based?
MEDIFAST's address is: 100 International Drive, Baltimore, MD, United States, 21202 What is MEDIFAST's ISIN number?
MEDIFAST's international securities identification number is: US58470H1014 What is MEDIFAST's CUSIP number?
MEDIFAST's Committee on Uniform Securities Identification Procedures number is: 42221F101
More guides on Finder
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert